1. R.N. Clayton, D. Raskauskiene, R.C. Reulen, P.W. Jones, Mortality and morbidity in Cushing’s disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. J. Clin. Endocrinol. Metab. (2011). doi: 10.1210/jc.2010-1942
2. A. Colao, M. Boscaro, D. Ferone, F.F. Casanueva, Managing Cushing’s disease: the state of the art. Endocrine (2014). doi: 10.1007/s12020-013-0129-2
3. D. Ferone, C. Pivonello, G. Vitale, M.C. Zatelli, A. Colao, R. Pivonello, Molecular basis of pharmacological therapy in Cushing’s disease. Endocrine (2014). doi: 10.1007/s12020-013-0098-5
4. A.B. Atkinson, A. Kennedy, M.I. Wiggam, D.R. McCance, B. Sheridan, Long-term remission rates after pituitary surgery for Cushing’s disease: the need for long-term surveillance. Clin. Endocrinol. (Oxf) 63(5), 549–559 (2005)
5. G.H. Chee, D.B. Mathias, R.A. James, P. Kendall-Taylor, Transsphenoidal pituitary surgery in Cushing’s disease: can we predict outcome? Clin. Endocrinol. (Oxf) 54(5), 617–626 (2001)